| Patents for C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media (9,992) |
|---|
| 02/14/2007 | EP1546388A4 Real time measurement of cellular responses |
| 02/14/2007 | CN1300320C Alzhimer's disease secretase |
| 02/13/2007 | US7176352 Enhancing genetic transformation by incubating the Lemnaceae plant tissue with the Agrobacterium cells in a medium contains caffeine; improve nutritional quality, disease resistance |
| 02/13/2007 | US7176326 β-Lactams, methods for the preparation of taxanes, and sidechain-bearing taxanes |
| 02/13/2007 | US7176288 Human coagulation factor VII variants |
| 02/13/2007 | US7176023 Endothelial cells derived from primate embryonic stem cells |
| 02/13/2007 | US7175762 Self-assembly; nanotubes; detectors |
| 02/13/2007 | US7174672 Method for the development of ruminant feed formulations |
| 02/08/2007 | WO2005052117A3 Improved methods of in vitro protein synthesis |
| 02/08/2007 | WO2005044987A3 Tocopherol associated protein and uses thereof |
| 02/08/2007 | WO2005010161A3 Device and method to facilitate directed delivery and electroporation |
| 02/08/2007 | WO2005001049A3 Compositions, splice variants and methods relating to ovarian specific genes and proteins |
| 02/08/2007 | WO2004108904A3 Porcine cmp-n-acetylneuraminic acid hydroxylase gene |
| 02/08/2007 | WO2004072260A3 Cell free assay systems for identifying a substance of interest |
| 02/08/2007 | US20070032421 Methods and compositions relating to cystatin C |
| 02/08/2007 | US20070032418 Small-molecule inhibitors of angiogenin and rnases and in vivo and in vitro methods of using same |
| 02/08/2007 | US20070032406 Identification of novel nogo-receptors and methods related thereto |
| 02/08/2007 | US20070032404 Methods for treating diabetes and related disorders using pde10a inhibitors |
| 02/08/2007 | US20070031956 Crystal structure of human PIM-1 kinase protein complexes and binding pockets thereof, and uses thereof in drug design |
| 02/08/2007 | US20070031882 Methods and compositions for treating AIDS and HIV-related disorders using 1414, 1481,1553, 34021, 1720, 1683, 1552, 1682, 1675, 12825, 9952, 5816, 10002, 1611, 1371, 14324, 126, 270, 312, 167, 326, 18926, 6747, 1793, 1784 or 2045 molecules |
| 02/08/2007 | US20070031880 Chemical treatment of biological samples for nucleic acid extraction and kits therefor |
| 02/07/2007 | EP1556491A4 Herbicide-resistant plants, and polynucleotides and methods for providing same |
| 02/07/2007 | EP1141308B1 Group b streptococcus proteins, and their use |
| 02/07/2007 | EP0796344B1 Method of detection of nucleic acids with a specific sequence composition |
| 02/07/2007 | CN1908014A Modified peptides as therapeutic agents |
| 02/07/2007 | CN1299117C Arrays of microparticles and methods of preparation thereof |
| 02/01/2007 | WO2004078923A3 Pyk2 crystal structure and uses |
| 02/01/2007 | US20070027634 Molecular hepatotoxicology modeling |
| 02/01/2007 | US20070027096 Aptamers to human epidermal growth factor receptor-3 |
| 02/01/2007 | US20070026403 Method and systems for identifying micro-rna targets and synthesizing novel micro-rnas and uses of the same |
| 02/01/2007 | US20070025967 Zap protein and related compositions and methods |
| 02/01/2007 | US20070025960 Bisphosphonates for prophylaxis and therapy against bioterrorism agents |
| 02/01/2007 | US20070025504 System for molecular imaging |
| 01/31/2007 | CN1906296A Methods for the production of apolipoproteins in transgenic plants |
| 01/31/2007 | CN1906292A Modificatory DNA incision enzyme and its application method |
| 01/31/2007 | CN1297566C DNA for encoding the RGI polypeptide |
| 01/30/2007 | US7171311 Methods of assigning treatment to breast cancer patients |
| 01/30/2007 | US7169905 Modified peptides as therapeutic agents |
| 01/30/2007 | US7169570 Method to identify regulators of cellular activation using Bcl10 |
| 01/30/2007 | US7169282 Dielectrophoresis apparatus |
| 01/30/2007 | CA2167693C Melanoma-inhibiting protein |
| 01/25/2007 | WO2005019420A3 Chimeric receptors with disrupted dileucine motifs |
| 01/25/2007 | WO2005019415A3 Compositions of orthogonal lysyl-trna and aminoacyl-trna synthetase pairs and uses thereof |
| 01/25/2007 | WO2004094611A3 Reprogramming nuclear function with somatic cell cytoplasm |
| 01/25/2007 | US20070022503 plant derived regulatory sequences and constructs and methods of using such sequences for directing expression of exogenous polynucleotide sequences in plants; exhibit a wide spectrum of promoter function patterns |
| 01/25/2007 | US20070021332 Helminth-derived antigens having capacity of providing protection against parasites |
| 01/25/2007 | US20070020722 Telomere elongation |
| 01/25/2007 | US20070020272 Indirectly linked photosensitizer immunoconjugates, processes for the production thereof and methods of use thereof |
| 01/25/2007 | US20070020242 Method for transdifferentiation of non-pancreatic stem cells to the pancreatic pathway |
| 01/24/2007 | EP0951536B1 Synthetic antisense oligodeoxynucleotides and pharmaceutical compositions containing them |
| 01/24/2007 | CN1901877A Compositions containing at least one oil structured with at least one silicone-polyamide polymer, and at least one gelling agent and methods of using the same |
| 01/24/2007 | CN1901803A Angiogensis models using nestin-expressing stem cells to image nascent blood vessels |
| 01/23/2007 | US7166707 Identifying peptide mimetic for treatment and prevention of tumors and autoimune diseases |
| 01/23/2007 | US7166692 comprises protein transduction domains; nuclear localization sequences; fusion proteins; for reversible immortalization of cells |
| 01/18/2007 | WO2007006864A2 Method for evaluating cell populations |
| 01/18/2007 | WO2005056771A3 In vitro uptake of spam 1 (ph-20) by mammalian sperm |
| 01/18/2007 | WO2005042695A3 Lipoparticles comprising proteins, methods of making, and using the same |
| 01/18/2007 | US20070015722 A first oligonucletide and a second are complimentary and hybridize with each other to a target nucleic acid for their use in modulating gene expression; hybridize to a portion of a target RNA resulting in loss of normal function of the target RNA |
| 01/18/2007 | US20070015156 Aberrantly methylated genes in pancreatic cancer |
| 01/18/2007 | US20070014724 inhibit the biological activity of multiple interferon (IFN) alpha subtypes but do not substantially inhibit the biological activity of IFN alpha 21, IFN beta or IFN omega; autoimmune diseases, transplant rejection and graft versus host disease; immunoconjugates |
| 01/18/2007 | CA2652767A1 Method for evaluating cell populations |
| 01/17/2007 | EP1654379A4 Methods and compositions for enhanced protein expression and purification |
| 01/11/2007 | US20070011774 Transgenic tobacco comprising nicotine biosynthetic gene in antisense orentation for decreasing nicotine concentration in tobacco; has DNA encoding a plant quinolate phosphoribosyl transferase (QPRTase) enzyme |
| 01/11/2007 | US20070010655 Stationary phases and a purification process using the stationary phases |
| 01/11/2007 | US20070009990 Site-specific incorporation of redox active amino acids into proteins |
| 01/11/2007 | US20070009894 Oligonucleotide sequestering agents and method of use |
| 01/11/2007 | US20070009520 Osteoclastogenesis inhibitory factor-binding molecule (OBM) specific immunoglobulin for use inhibiting osteoclast inhibitory factor (OCIF) binding activity and treating bone disorders |
| 01/10/2007 | EP1741777A1 Compositions comprising viruses and methods for concentrating virus preparations |
| 01/10/2007 | EP1355916B1 Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase |
| 01/10/2007 | CN1894581A Method for assaying protein-protein interaction |
| 01/10/2007 | CN1894412A P EF-TU expression units |
| 01/10/2007 | CN1894408A Metabolic protein for weed-control agent, its gene, and its use |
| 01/10/2007 | CN1894401A Derivation of terminally differentiated dopaminergic neurons from human embryonic stem cells |
| 01/10/2007 | CN1891833A Enzyme reaction method for nucleic acid and composition for separating nucleic acid |
| 01/04/2007 | WO2005033275A3 Methods for altering hematopoietic progenitor cell adhesion, differentiation, and migration |
| 01/04/2007 | WO2005028634A3 Improved mva vaccines |
| 01/04/2007 | WO2005017488A3 Method and system for identifying biological entities in biological and environmental samples |
| 01/04/2007 | WO2005012491A3 Surface expression of biologically active proteins in bacteria |
| 01/04/2007 | US20070004621 Bex4 nucleic acids, polypeptides, and method of using |
| 01/04/2007 | US20070004016 Expression vector comprising nucleotide sequences coding desaturase for use in transformation of yeast and propagation of eicosapentaenoic, gamma-linoleic and stearidonic acids; bioreactors |
| 01/04/2007 | US20070003963 RNA sequence-specific mediators of RNA interference |
| 01/04/2007 | US20070003962 Used in targeting specific mRNAs for degradation in mammalian cells where use of long dsRNAs to elicit RNAi is usually not practical, presumably because of the deleterious effects of the interferon response |
| 01/04/2007 | US20070003961 Used in targeting specific mRNAs for degradation in mammalian cells where use of long dsRNAs to elicit RNAi is usually not practical, presumably because of the deleterious effects of the interferon response |
| 01/04/2007 | US20070003960 Producing knockdown cells; Used in targeting specific mRNAs for degradation in mammalian cells where use of long dsRNAs to elicit RNAi is usually not practical, presumably because of the deleterious effects of the interferon response |
| 01/04/2007 | US20070003956 Approaches to identifying genetic traits in animals |
| 01/04/2007 | US20070003931 Methods for selecting medications |
| 01/04/2007 | US20070003548 Anti-TNF antibodies, compositions, methods and uses |
| 01/03/2007 | EP1685245A4 A process of making transgenic mammals that produce exogenous proteins in milk and transgenic mammals produced thereby |
| 01/03/2007 | EP0526452B2 Hybrid immunoglobulins |
| 01/03/2007 | CN1889978A Interferon alpha antibodies and their uses |
| 01/02/2007 | US7157256 Method for producing para-hydroxystyrene and other multifunctional aromatic compounds using two-phase extractive fermentation |
| 01/02/2007 | US7157088 Surface protein of Leptospira |
| 12/28/2006 | WO2006138466A2 Alternate morpheeins of allosteric proteins as a target for the development of bioactive molecules |
| 12/28/2006 | WO2006138259A2 Chemokine receptor binding compounds |
| 12/28/2006 | WO2005042701A3 Methods to identify compounds useful for tumor sensitization to dna damage |
| 12/28/2006 | US20060294604 Model for studying the role of genes in tumor resistance to chemotherapy |
| 12/28/2006 | US20060293239 Treatment and Diagnosis of Insulin-Resistant States |
| 12/28/2006 | US20060293230 Expression and secretion of icIL-1 receptor antagonist type II |
| 12/28/2006 | US20060292621 Randomized libraries of zinc finger proteins |
| 12/28/2006 | US20060289023 Filter containing a metal phthalocyanine and polycationic polymer |